JPRN-UMIN000006434已完成2 期
Randomized Phase II Trial of Anastrozole plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer - Neo-ACET BC
Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine0 个研究点目标入组 120 人开始时间: 2011年9月29日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Inoperable, multiple, bilateral (synchronous or asynchronous) or inflammatory breast cancer 2.Personal history of invasive carcinoma 3.Patients receive systemic therapy of corticosteroid 4.Patients receive estrogen preparation or raloxifene 5.Patients with other concurrent severe and/or uncontrolled medical disease 6.Patients whom doctors judged inadequate to the enrollment of this study by other reasons.
研究者
相似试验
进行中（未招募）
不适用
A randomised Phase II Study comparing anastrozole and fulvestrant to an-astrozole for adjuvant treatment of postmenopausal patients with early breast cancer and disseminated tumour cells in bone marrow - ABCSG 21postmenopausal women with hormone receptor positive early breast cancerEUCTR2005-005715-22-ATAstraZeneca AB176
进行中（未招募）
1 期
A randomised Phase II Study comparing anastrozole and fulvestrant to an-astrozole for adjuvant treatment of postmenopausal patients with early breast cancer and disseminated tumour cells in bone marrow - ABCSG 21EUCTR2005-005715-22-NOAstraZeneca AB176
进行中（未招募）
不适用
A randomised Phase II Study comparing anastrozole and fulvestrant to anastrozole for adjuvant treatment of postmenopausal patients with early breast cancer and disseminated tumour cells in bone marrow - ABCSG 21EUCTR2005-005715-22-DEAstraZeneca AB176
已完成
不适用
STUDY RANDOMIZED PHASE II, COMBINATION OF ANASTROZOL (NSC 719344) MAS ZD1839 (IRESSA, NSC No. 715055, IND No. 61187) AND THE COMBINATION OF FULVESTRANT (NSC · 719276) MAS ZD1839 IN THE TREATMENT OF POSTMENOPAUS WOMEN WITH CANCER OF METASTASIC MAMA AND POSITIVE HORMONAL RECEPTORSPER-101-03EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),
已完成
2 期
A randomized controlled study comparing Anastrozole+TS-1 as postoperative chemotherapy in ER positive metastatic breast cancerBreast CancerJPRN-UMIN000000795Department of Breast and Thyroid Surgery, Kawasaki Medical School100